Grand A, Ghadban W, Perret S P, Saboul R, Mosnier S, Douieb A, Fichter P, Huret J F
Service de Cardiologie, Centre Hospitalier de Valence.
Ann Cardiol Angeiol (Paris). 1996 Nov;45(9):517-22.
A 27-year-old woman, after 31 weeks of amenorrhoea during her second pregnancy, developed a left external iliac and femoral deep vein thrombosis, confirmed by venous ultrasonography and magnetic resonance imaging. The infusion of tissue plasminogen activator (rt-PA: 1.2 mg/kg, i.e. 80 mg over 3 hours), on the 2nd day, allowed revascularization of the femoral junction, while the external iliac vein remained occluded. The patient did not develop pulmonary embolism or haemorrhage, particularly obstetric haemorrhage. The subsequent pregnancy was uneventful until delivery, six weeks later, of a normal child. Three years later, the patient has no sequelae of her deep vein thrombosis. When required by the patient's condition, it seems that rt-PA can be used to treat severe deep vein thrombosis during pregnancy, either isolated or complicated by pulmonary embolism. Very rigorous cardiological, obstetric and laboratory surveillance is essential. A sufficient dosage, identical to that used in clinical settings other than pregnancy and a brief treatment duration (2 to 3 hours) are probably more effective and more reliable than lower doses continued for several days. However, the risk of haemorrhage remains difficult to predict and its prognosis, especially foetal, is often very poor. A larger series of cases is therefore necessary before this drug can unreservedly recommended in pregnant women.
一名27岁女性,在第二次怀孕停经31周时,发生左髂外静脉和股深静脉血栓形成,经静脉超声和磁共振成像确诊。在第2天输注组织型纤溶酶原激活剂(rt-PA:1.2mg/kg,即3小时内输注80mg)后,股静脉交界处实现再通,而髂外静脉仍闭塞。患者未发生肺栓塞或出血,尤其是产科出血。随后的妊娠过程顺利,直至6周后分娩出一名正常婴儿。3年后,患者深静脉血栓形成无后遗症。根据患者病情需要,rt-PA似乎可用于治疗妊娠期严重深静脉血栓形成,无论是孤立性的还是合并肺栓塞的。非常严格的心脏、产科和实验室监测至关重要。与非妊娠临床情况使用的剂量相同的足够剂量以及较短的治疗持续时间(2至3小时)可能比持续数天的低剂量更有效、更可靠。然而,出血风险仍然难以预测,其预后,尤其是胎儿预后,往往非常差。因此,在无保留地推荐该药物用于孕妇之前,需要更多的病例系列研究。